Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Docetaxel|DRUG: Capecitabine|DRUG: Docetaxel/Capecitabine
Sponsor: Georgia Center for Oncology Research & Education
Collaborators: Sanofi